v3.22.1
Statements of Operations (unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating expenses:    
Research and development $ 1,595,839 $ 680,588
General and administrative 1,190,313 1,581,185
Total operating expenses 2,786,152 2,261,773
Loss from operations (2,786,152) (2,261,773)
Other income and expenses:    
Interest expense, net 0 43,135
Net loss $ (2,786,152) $ (2,304,908)
Net loss per share of common stock, basic and diluted $ (0.33) $ (1.21)
Weighted-average basic and diluted common units/shares 8,352,459 1,911,009

Source